Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
8310cov1open.jpg

March 7, 2005 Cover

Volume 83, Issue 10

Drug delivery companies hold on to technologies longer with ultimate goal of commercializing proprietary products themselves

Credit:

Full Article
Volume 83 | Issue 10

All Issues

Pharmaceuticals

Morphing the Model

Drug delivery companies hold on to technologies longer with ultimate goal of commercializing proprietary products themselves

  • Patent Pending

    A series of Japanese patent disputes raises questions about employee patent rights

  • Robbing Peter to Pay Paul

    Pentagon seeks ways to fund chemical weapons destruction and meet a treaty deadline

  • A Vision Realized

    DSM Chairman Elverding reflects on completion of revamp program

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT